Solid Tumors
3 competing products in clinical development for Solid Tumors.
Pipeline by Phase
Phase 12
Phase 21
All Products (3)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tomivosertib (eFT-508) | eFFECTOR Therapeutics | Phase 2 | Completed | 44 |
| E7050 | Eisai | Phase 1 | Completed | 33 |
| LY2875358 + Erlotinib + Gefitinib | Eli Lilly | Phase 1 | Completed | 33 |